Ser571

Site Information
rLLsPLssARLPPEP SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 4773958

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 )
Disease tissue studied:	lung cancer ( 1 ) , non-small cell lung cancer ( 1 )
Relevant cell line - cell type - tissue:	Flp-In T-Rex-293 (epithelial) [PRKD1 (human), genetic knockin] ( 2 ) , Flp-In T-Rex-293 (epithelial) ( 2 ) , H2009 (pulmonary) ( 1 ) , H2887 (pulmonary) ( 1 ) , HOP62 (pulmonary) ( 1 ) , LOU-NH91 (squamous) ( 1 ) , NCI-H322 (pulmonary) ( 1 ) , NCI-H460 (pulmonary) ( 1 )

References
1	Klammer M, et al. (2012) Phosphosignature predicts dasatinib response in non-small cell lung cancer. Mol Cell Proteomics 11, 651-68 22617229 Curated Info
2	Franz-Wachtel M, et al. (2012) Global detection of protein kinase D-dependent phosphorylation events in nocodazole-treated human cells. Mol Cell Proteomics 11, 160-70 22496350 Curated Info